Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

José A. Pérez-Molina, Rosa Polo, José López-Aldeguer, Fernando Lozano, Koldo Aguirrebengoa, José Ramón Arribas, Vicente Boix, Juan Berenguer, José Ramón Blanco, Pere Domingo, Vicente Estrada, María José Galindo, Federico García, José María Gatell, Juan González-García, Félix Gutiérrez, José Antonio Iribarren, Hernando Knobel, Josep María Llibre, Juan Carlos López-Bernaldo de QuirósLuis Fernando López-Cortés, Juan Emilio Losa, Ana Mariño, José M. Miró, María L. Montes, Santiago Moreno, Eugenia Negredo, María J. Pérez-Elías, Daniel Podzamczer, Joaquín Portilla, Eva Poveda, Federico Pulido, Esteban Ribera, Antonio Rivero, Rafael Rubio, Jesús Santos, José Sanz-Moreno, Jesús Sanz-Sanz, Sergio Serrano, Javier de la Torre, Montserrat Tuset, Miguel A. von Wichman, Esteban Martínez

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

© 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica This update to the document on antiretroviral therapy (ART) in adults, which has been prepared jointly by GeSIDA and the Spanish National AIDS Plan for the last two decades, supersedes the document published in 2017. 1 The update provides physicians treating HIV-1-infected adults with evidence-based recommendations to guide their therapeutic decisions. The main difference with respect to the previous document concerns recommended initial ART regimens, only three of which are maintained as preferential. All three include dolutegravir or raltegravir, together with emtricitabine/tenofovir alafenamide or abacavir/lamivudine. Other differences concern the section on switching ART in patients with suppressed viral replication, which now includes new two- and three-drug regimens, and the antiretroviral drugs recommended for pregnant women and patients with tuberculosis. A recommendation has also been added for patients who present with acute HIV infection after pre-exposure prophylaxis.
Original languageAmerican English
Pages (from-to)195-202
Number of pages8
JournalEnfermedades Infecciosas y Microbiologia Clinica
Volume37
Issue number3
DOIs
Publication statusPublished - 1 Mar 2019

Keywords

  • AIDS
  • Antiretroviral therapy
  • Clinical guidelines
  • GeSIDA
  • Human immunodeficiency virus
  • Recommendations
  • Spanish National AIDS Plan

Fingerprint Dive into the research topics of 'Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)'. Together they form a unique fingerprint.

Cite this